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Purpose
Recent studies have implicated low vitamin D levels with
greater disease activity in pediatric systemic lupus erythe-
matosus (SLE) and we have reported an association
between low vitamin D levels and greater disease activity in
juvenile dermatomyositis. The objective of this study was
to explore whether standardized vitamin D supplementa-
tion of low levels of 25-hydroxyvitamin D [25(OH)D]
might be associated with improvements in disease activity.
Methods
Subjects diagnosed with JDM or SLE prior to the age of 18
were consented and given a questionnaire regarding
demographics, sunscreen use, and dietary habits to assess
conventional risk factors for vitamin D deficiency. Serum
25(OH)D was determined. Disease activity was rated using
a 10-cm physician’s global assessment (PGA) in all sub-
jects and a SLE disease activity index (SLEDAI) in subjects
with SLE. All subjects with serum 25(OH)D levels less
than 30ng/mL were given ergocalciferol 50,000 IU weekly
for 8 weeks, and serum 25(OH)D levels, PGA, and SLE-
DAI were reevaluated at their next routine follow up visit.
T-tests and linear regression were used to examine the
association between change in PGA or SLEDAI with
change in serum 25(OH)D levels after supplementation.
Results
There were 58 subjects; 21 with JDM and 37 with SLE. At
baseline, 31/37 or 84% of subjects with SLE had serum 25
(OH)D < 30 ng/mL, and 13/21 or 62% of subjects with
JDM had serum 25(OH)D < 30 ng/mL. 23 subjects with
SLE and 11 subjects with JDM had followup serum 25
(OH)D levels and disease activity scores available for analy-
sis. Among all 34 subjects, there was an overall association
between decrease in PGA and improvement in serum 25
(OH)D after supplementation. For every 1 point improve-
ment in 25(OH)D, there was a mean decrease in PGA by
0.07 cm (95% CI 0.01-0.13cm) (p = 0.02). Looking indepen-
dently at subjects with SLE and JDM, there was a trend
towards an association between decreased PGA or SLEDAI
and better response to supplementation, but these associa-
tions were not significant.
Conclusion
Results are suggestive that there may be an improve-
ment in disease activity associated with better response
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Table 1 Mean change in disease activity compared by serum 25-hydroxyvitamin D sufficiency or insufficiency after
treatment
Follow up 25(OH)D < 30 ng/mL Follow up 25(OH)D >= 30 ng/mL p-value
Overall mean change in PGA (n=34) 0.1 cm -1.6 cm 0.08
Mean change in PGA among SLE (n=23) 0.2 cm -0.6 cm 0.47
Mean change in PGA among JDM (n=11) -0.2 cm -3.0 cm 0.15
Mean change in SLEDAI (n=23) -1.6 -4.3 0.36
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to vitamin D supplementation in children with SLE and
JDM. This pilot study can be used only for hypothesis
generation; it is underpowered to look at possible con-
founding by other medications or other factors, but sug-
gest that a larger study to look prospectively at the
effect of vitamin D supplementation on disease activity
in these two diseases is warranted.
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